Evidence map›Paper›PMID 35169700›Full record

ReviewBrain communications2022

Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis.

James B Badenoch, Emma R Rengasamy, Cameron Watson, Katrin Jansen, Stuti Chakraborty, Ritika D Sundaram, Danish Hafeez, Ella Burchill, Aman Saini, Lucretia Thomas and 13 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Brain communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06940609 (Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation), which is not on this map. Cited by 142 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed, 10 pooled it
24.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06940609 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation (MANIFEST)

TypeinterventionalSponsorUniversity of New MexicoRan2025 to 2029Enrolled60ConditionsLong COVID, Long COVID Syndrome, Long COVID-19 Syndrome, PASCArmsaccelerated intermittent theta burst stimulation
3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 10 syntheses or guidelines pooled it, 281 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Toward characterizing brain fog in long COVID: correlates and impact on measurement metrics.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  19. Association between COVID-19 diagnosis and severe mental health symptoms in adolescents in southern Brazil.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2026
    Article
  20. Review

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 18 institutions in 4 countries.

James B BadenochBarts Health NHS Trust, London, UK.ORCID https://orcid.org/0000-0002-6994-6916
Emma R RengasamyDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Cameron WatsonBarts Health NHS Trust, London, UK.
Katrin JansenDepartment of Psychology, University of Münster, Münster, Germany.
Stuti ChakrabortyDepartment of Physical Medicine and Rehabilitation, Christian Medical College and Hospital, Vellore, India.
Ritika D SundaramSchool of Medicine, University of Glasgow, Glasgow, UK.
Danish HafeezHomerton University Hospitals Foundation Trust, London, UK.ORCID https://orcid.org/0000-0003-3712-136X
Ella BurchillFaculty of Medicine and Life Sciences, King's College London, London, UK.ORCID https://orcid.org/0000-0002-1674-8844
Aman SainiMedical School, University College London, London, UK.
Lucretia ThomasCollege of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Benjamin CrossEast Lancashire Hospitals NHS Trust, Lancashire, UK.
Camille K HuntWarwick Medical School, Coventry, UK.
Isabella ContiSchool of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Sylvia RalovskaSofia University 'St Kliment Ohridski', bul, 'Tsar Osvoboditel' 15, Sofia, Bulgaria.
Zain HussainEdinburgh Medical School, College of Medicine and Veterinary Medicine, University of Edinburgh, UK.
Matthew ButlerInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Thomas A PollakDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0002-6171-0810
Ivan KoychevDepartment of Psychiatry, University of Oxford, Oxford, UK.
Benedict D MichaelDepartment of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.
Heinz HollingDepartment of Psychology, University of Münster, Münster, Germany.
Timothy R NicholsonSection of Cognitive Neuropsychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Jonathan P RogersDivision of Psychiatry, University College London, London, UK.ORCID https://orcid.org/0000-0002-4671-5410
Alasdair G RooneyCentre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.
King's College London · GBQueen Mary University of London · GBUniversity of Münster · DEChristian Medical College, Vellore · INEast Lancashire Hospitals NHS Trust · GBHomerton University Hospital NHS Foundation Trust · GBQueen's University Belfast · GBSofia University "St. Kliment Ohridski" · BGSouth London and Maudsley NHS Foundation Trust · GBUniversity College London · GBUniversity of Birmingham · GBUniversity of Cambridge · GBUniversity of Dundee · GBUniversity of Edinburgh · GBUniversity of Glasgow · GBUniversity of Liverpool · GBUniversity of Oxford · GBUniversity of Warwick · GB

Funding

Medical Research Council MR/J000914/1MRF_ C0396Wellcome Trust
6 · The paper itself

Abstract

The nature and extent of persistent neuropsychiatric symptoms after COVID-19 are not established. To help inform mental health service planning in the pandemic recovery phase, we systematically determined the prevalence of neuropsychiatric symptoms in survivors of COVID-19. For this pre-registered systematic review and meta-analysis (PROSPERO ID CRD42021239750), we searched MEDLINE, EMBASE, CINAHL and PsycINFO to 20 February 2021, plus our own curated database. We included peer-reviewed studies reporting neuropsychiatric symptoms at post-acute or later time-points after COVID-19 infection and in control groups where available. For each study, a minimum of two authors extracted summary data. For each symptom, we calculated a pooled prevalence using generalized linear mixed models. Heterogeneity was measured with

Indexed as

chronic COVID syndromeCOVID-19Long COVIDneuropsychiatrypost-acute sequelae of COVID-19

Identifiers

PMID35169700
PMCPMC8833580
OpenAlexW4205354784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.